Buscador de publicacions

Publicacions

  • Barrau Sastre, Paula, Birulés-Muntané I, Verdaguer M, López-Carrilero R, Ferrer Quintero, Marta, García-Mieres H, Diaz L, Eva Maria Grasa Bello, Esther Pousa Tomas, ESTHER LORENTE ROVIRA, Peláez MT, Maria Luisa Barrigon Estevez, Isabel Ruiz Delgado, Fermín González Higueras, Jordi Cid Colom, Jose Alfonso Gutierrez Zotes, Cuadras-Palleja D, Usall J, Vila R, Barajas A, Ochoa S and Spanish Metacognition Group.

    Influence of Menstrual Cycle Length and Age at Menarche on Symptoms, Cognition, Social Cognition, and Metacognition in Patients with First-Episode Psychosis

    Women . 2: 135-146. Nº de cites: 2

    [doi:10.3390/women2020015]

  • Sánchez-Torres AM, Peralta V, Gil-Berrozpe GJ, Mezquida G, Ribeiro M, Molina-García M, Amoretti S, Lobo A, González-Pinto A, Merchán-Naranjo J, Corripio I, Vieta E, de la Serna E, Bergé D, Bernardo M and Cuesta MJ.

    The network structure of cognitive deficits in first episode psychosis patients.

    SCHIZOPHRENIA RESEARCH . 244: 46-54. Nº de cites: 1

    [doi:10.1016/j.schres.2022.05.005]

  • Moreno-Küstner B, Fábrega-Ruz J, Gonzalez-Caballero JL, Reyes S, Ochoa S, Romero-Lopez-Alberca C, Cid J, Vila R, Frigola-Capell E and Salvador-Carulla L.

    Patient-reported impact of symptoms in schizophrenia scale (PRISS): Development and validation.

    ACTA PSYCHIATRICA SCANDINAVICA . 145(6): 640-655. Nº de cites: 2

    [doi:10.1111/acps.13417]

  • Bioque M, Mezquida G, Amoretti S, García-Rizo C, López-Ilundain JM, Diaz-Caneja CM, Zorrilla I, Mané A, Rodriguez-Jimenez R, Corripio I, Pomarol-Clotet E, Ibáñez Á, Usall J, Contreras F, Mas S, Vázquez-Bourgon J, Cuesta MJ, Parellada M, González-Pinto A, Hidalgo-Figueroa M, Bernardo M and 2EPs GROUP.

    Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia.

    SCHIZOPHRENIA RESEARCH . 243: 32-42. Nº de cites: 17

    [doi:10.1016/j.schres.2022.02.026]

  • Mortier P, Gemma Vilagut Saiz, Alayo I, Ferrer M, Amigo F, Aragonès E, Aragón-Peña A, Asúnsolo Del Barco A, Campos M, Espuga M, González-Pinto A, Haro JM, López Fresneña N, Martínez de Salázar A, Molina JD, Ortí-Lucas RM, Parellada M, Pelayo-Terán JM, Pérez-Gómez B, Pérez-Zapata A, Pijoan JI, Plana N, Polentinos-Castro E, Portillo-Van Diest A, Puig MT, Rius C, Sanz F, Serra C, Urreta-Barallobre I, Kessler RC, Bruffaerts R, Vieta E, Pérez-Solá V, Alonso J and MINDCOVID Working group.

    Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic.

    JOURNAL OF PSYCHIATRIC RESEARCH . 149: 10-17. Nº de cites: 11

    [doi:10.1016/j.jpsychires.2022.02.009]

  • Rodríguez N, Gassó P, Martínez-Pinteño A, Segura ÀG, Mezquida G, Moreno-Izco L, González-Peñas J, Zorrilla I, Martin M, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibáñez A, Butjosa A, Contreras F, Bioque M, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M and Mas S.

    Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients.

    SCHIZOPHRENIA . 8(1): 45-45. Nº de cites: 2

    [doi:10.1038/s41537-022-00215-1]

  • Diaz L, López-Carrilero R, García-Mieres H, Ferrer-Quintero M, Verdaguer M, Barajas A, Eva Maria Grasa Bello, Esther Pousa Tomas, ESTHER LORENTE ROVIRA, Barrigón ML, Isabel Ruiz Delgado, González-Higueras F, Jordi Cid Colom, Mas-Expósito L, Corripio I, Birulés-Muntané I, Peláez MT, Luengo A, Beltran M, Torres-Hernández P, Palma-Sevillano C, Moritz S, Garety P and Ochoa S.

    The relationship between jumping to conclusions and social cognition in first-episode psychosis.

    SCHIZOPHRENIA . 8(1): 39-39. Nº de cites: 6

    [doi:10.1038/s41537-022-00221-3]

  • Arranz B, Garriga M, Bernardo M, González-Pinto A, Arrojo M, Torrens M, Tirado-Muñoz J, Fonseca F, Sáiz PA, Flórez G, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, Angeles López Ponce and San L.

    Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use.

    Adicciones . 34(2): 110-127. Nº de cites: 5

    [doi:10.20882/adicciones.1504]

  • Martínez-Pinteño A, Mezquida G, Bioque M, López-Ilundain JM, Andreu-Bernabeu Á, Zorrilla I, Mané A, Rodríguez-Jiménez R, Corripio I, Sarró S, Ibáñez Á, Usall J, Rivero O, Gassó P, Leza JC, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Mas S, Bernardo M and 2EPs Group.

    The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 57: 105-117. Nº de cites: 6

    [doi:10.1016/j.euroneuro.2022.02.003]

  • Cunill R, Castells X, González-Pinto A, Arrojo M, Bernardo M, Sáiz PA, Florez G, Torrens M, Tirado-Muñoz J, Fonseca F, Arranz B, Garriga M, Goikolea JM, Zorrilla I, Becoña E, Angeles López Ponce and San L.

    Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use.

    Adicciones . 34(2): 168-178. Nº de cites: 4

    [doi:10.20882/adicciones.1569]